Summit Trail Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Summit Trail Advisors's EXEL Position: Q2 2026 in Review
Summit Trail Advisors reduced its Exelixis (EXEL) stake by 0.58% in Q2 2026, selling an estimated $4.77K and leaving 16,756 shares worth $912K. The position accounts for 0.01% of the portfolio, ranked #1022.
Summit Trail Advisors first reported a position in EXEL in Q4 2017 and has held it in 8 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Summit Trail Advisors held 16,756 shares of Exelixis worth $912K as of Q2 2026.
- Summit Trail Advisors sold 98 Exelixis shares in Q2 2026, an estimated $4.77K.
- Exelixis made up 0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1022 holding.
- Summit Trail Advisors first reported a position in Exelixis in Q4 2017 and has held it in 8 quarters since.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.